Invesque Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Invesque in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Invesque stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IVQ, but not buy additional shares or sell existing shares.
View analyst ratings for Invesque or view top-rated stocks.

Wall Street analysts have given Invesque a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Invesque wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Invesque is scheduled to release its next quarterly earnings announcement on Wednesday, March 10th 2021.
View our earnings forecast for Invesque.

Invesque's stock was trading at C$7.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IVQ shares have decreased by 58.9% and is now trading at C$2.98.
View which stocks have been most impacted by COVID-19.

Invesque declared a monthly dividend on Monday, March 9th. Stockholders of record on Tuesday, March 31st will be paid a dividend of 0.061 per share on Wednesday, April 15th. This represents a $0.73 dividend on an annualized basis and a dividend yield of 24.56%. The ex-dividend date of this dividend is Monday, March 30th.
View Invesque's dividend history.

3 brokerages have issued 12-month price objectives for Invesque's stock. Their forecasts range from C$4.50 to C$5.50. On average, they anticipate Invesque's stock price to reach C$5.00 in the next year. This suggests a possible upside of 67.8% from the stock's current price.
View analysts' price targets for Invesque or view top-rated stocks among Wall Street analysts.

Some companies that are related to Invesque include Uniphar (UPR), Sourcebio International (SBI), NMC Health (NMHLY), Assure (ARHH), Asian American Medical Group (AJJ), CareRx (CHHHF), Encompass Health (EHC), FarmaForce Limited (FFC.AX) (FFC), Field Trip Health (FTRPF), Fresenius SE & Co. KGaA (FRE), Greenbrook TMS (GBOKF), Greenbrook TMS (GBOKD), Healthia (HLA), JD Health International (JDHIF) and Life Healthcare Group (LTGHY).
View all of IVQ's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Invesque investors own include HD Supply (HDS), Brookline Bancorp (BRKL), Forum Energy Technologies (FET), TransAlta Renewables (RNW), SNC-Lavalin Group (SNC), AltaGas (ALA), Chemtrade Logistics Income Fund (CHE.UN), Chorus Aviation (CHR), Exchange Income (EIF) and American Hotel Income Properties REIT (HOT.UN).

Invesque trades on the Toronto Stock Exchange (TSX) under the ticker symbol "IVQ."

Shares of IVQ and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

One share of IVQ stock can currently be purchased for approximately C$2.98.

Invesque has a market capitalization of C$166.45 million and generates C$207.60 million in revenue each year.

Invesque employs 1,453 workers across the globe.

The official website for Invesque is invesque.com.

The company can be reached via phone at 317-643-4017.